Results 151 to 160 of about 5,234,907 (203)

Author Response on: Immune checkpoint inhibitor therapy for treatment of periocular merkel cell carcinoma: A systematic review of clinical outcomes and safety. [PDF]

Indian J Ophthalmol
Folk GA, Lee W, Shoji MK.
europepmc   +1 more source

Case report of metastatic Merkel cell carcinoma presenting as purpuric chest discoloration. [PDF]

JAAD Case Rep
Glienke J, Burris J, Rietkerk W.
europepmc   +1 more source

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models. [PDF]

J Clin Invest
Ananthapadmanabhan V, Bruno S, Vonk L, Cheng YC, Teshager A, Eschle BK, Howarth CL, Rodrigues JS, Schnabel J, Kodali A, Gokhale PC, Kshirsagar R, Breitkopf SB, Sharma K, Paulo JA, Li Y, Cherniack AD, Michor F, Chutake Y, Dey J, DeCaprio JA.   +20 more
europepmc   +1 more source

Merkel Cell Carcinoma in Queensland: Treatment, Incidence and Outcomes Over a 10-Year Period (2012-2021). [PDF]

Australas J Dermatol
Youlden DR, Gujadhur S, Nath A, Woodrow P, Moore J, Xu W, Burmeister BH.   +6 more
europepmc   +1 more source

Rapidly Enlarging Forearm Mass in a 74-Year-Old Male: A Case of Merkel Cell Carcinoma Presenting as a Soft Tissue Tumor. [PDF]

Cureus
Ziegler SA, Zimmer CR, Ziegler B.
europepmc   +1 more source

High tumor mutational burden and PIK3CA mutations correlate with poor Merkel cell carcinoma-specific survival. [PDF]

JCI Insight
Lobo M, Bahar F, Schnabel JL, Neto JPD, Shetty A, Khaddour K, Thakuria M, Silk AW, DeCaprio JA.   +8 more
europepmc   +1 more source

Advanced Merkel cell carcinoma resulting in palliative amputation. [PDF]

JAAD Case Rep
Saito Y, Strong J, Bakayoko A, Yu J, Ng VY, Moresi JM.   +5 more
europepmc   +1 more source

A rare presentation of Merkel cell carcinoma in a young immunocompetent woman. [PDF]

JAAD Case Rep
Saka F, Kannan A, Das B, O'Leary MP, Fanucci LA, Chambers M, Lambrecht N, Gao L.   +7 more
europepmc   +1 more source

Merkel cell carcinoma with in-transit metastases: Complete response after intralesional interleukin-2 therapy. [PDF]

JAAD Case Rep
Vidal González A, López Alcázar S, Feltes Ochoa R, Gil Redondo R, Herranz Pinto P, Mayor Ibarguren A.   +5 more
europepmc   +1 more source